Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| An Ounce of Prevention: Deaths Averted From Primary Prevention Interventions. | Academic Article |
Why?
|
| Applicability of cholesterol-lowering primary prevention trials to a general population: the framingham heart study. | Academic Article |
Why?
|
| Aspirin and nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: weighing the evidence. | Academic Article |
Why?
|
| Aspirin for Primary Prevention: Clinical Considerations in 2019. | Academic Article |
Why?
|
| Decision making in cancer primary prevention and chemoprevention. | Academic Article |
Why?
|
| Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease. | Academic Article |
Why?
|
| Primary prevention drug therapy: can it meet patients' requirements for reduced risk? | Academic Article |
Why?
|
| Special issues related to randomized trials of primary prevention. | Academic Article |
Why?
|
| Primary prevention, aging, and cancer: overview and future perspectives. | Academic Article |
Why?
|
| A Long-term Benefit Approach vs Standard Risk-Based Approaches for Statin Eligibility in Primary Prevention. | Academic Article |
Why?
|
| A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. | Academic Article |
Why?
|
| Aspirin for primary prevention of vascular events in women: individualized prediction of treatment effects. | Academic Article |
Why?
|
| Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians. | Academic Article |
Why?
|
| Low-dose aspirin in the primary prevention of rheumatoid arthritis: the Women''s Health Study. | Academic Article |
Why?
|
| Predictors of adherence to statins for primary prevention. | Academic Article |
Why?
|